Export
The link always opens the latest version of this page.
Ask an AI about it
Open in ChatGPTA new chat that reads this entry from the site Open in ClaudeThe same, in ClaudeShare the link instead of a file, and they will always see the latest version.
Files are a snapshot of today. The live page has anything newer.
Ozempic
GLP-1 medication for weight management
- Vendor
- Novo Nordisk 1 source
- Category
- GLP-1 receptor agonist 1 source
Ozempic is a glp-1-receptor-agonist medication manufactured by Novo Nordisk 1 used for weight management and glycemic control.
The medication has been the subject of an extended compulsory licensing application 2, a legal mechanism that allows governments to authorize production of patented drugs without the patent holder's consent under specified conditions.
Facts 2
| Attribute | Value | Confidence | Sources | Cited |
|---|---|---|---|---|
| Vendor | Novo Nordisk | low | 1 | 1 |
| Category | GLP-1 receptor agonist | low | 1 | source ↗ |
Neighbourhood
Developed by 1
Superseded by 1
Official links
Frequently mentioned together 11
Sources 16
- Semaglutide’s heart benefits may partly involve reduced inflammation - News-Medical · Google News: Hacking
- video The Economics of Immortality: What Happens If We Live Forever? · Science & Futurism with Isaac Arthur
- FDA Warns GLP-1s May Increase Risk of Sudden Blindness · Slashdot
- Knee osteoarthritis pain relief – and massive weight loss – from new GLP-1 · New Atlas
- video How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski · Huberman Lab
5 of 16 sources shown · Pro unlocks the full list